Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

Share Price is delayed by 15 minutes
Get Live Data
1,050.00    -69.00 (-6.17%)
Bid:
1,050.50
Ask:
1,051.50
Spread: 1.00 (0.095%)
Market Cap: £3.37b
PSN Live PriceLast checked at - London Stock Exchange

Intraday Persimmon Share Chart

Third Quarter Trading Statement

4 Nov 2015 07:00

RNS Number : 4508E
Persimmon PLC
04 November 2015
Ā 

THIRD QUARTER TRADING STATEMENT

Ā 

WEDNESDAY 4 NOVEMBER 2015

Ā 

Persimmon plc today releases its third quarter Trading Statement which covers the period from 1 July 2015 to 3 November 2015.

Ā 

As we moved into the autumn selling season customer activity strengthened in line with the traditional seasonality of the market. Our private sales rate in the period since we reported our half year results on 18 August 2015 was 12% ahead of last year, building on the 5% stronger sales rate through the summer weeks. The level of customer interest in our sites has been encouraging with visitor numbers running 5% ahead of last year. Pricing remains robust across our regional markets.

Ā 

Mortgage approval volumes have continued the positive trend established since the start of the second quarter with approvals for house purchase in September 13% ahead year on year. Mortgage interest rates have remained at attractive levels. With the introduction of improved regulation and Bank of England oversight measures mortgage lenders are required to remain disciplined credit providers. These structural improvements in the mortgage market will, we believe, support a more stable and sustainable outlook for the housing market in the UK in the future.

Ā 

We expect the Group to continue to generate strong growth having successfully opened 105 new housing developments in the second half to date. This success in achieving implementable detailed planning consents and maintaining the strength of our outlet network is critically important in delivering increased new housing volumes to local communities across the UK. We anticipate opening a further c. 20 new sites in the remaining weeks of this year.

Ā 

Our growth is further supported by establishing new regional businesses. The Group opened two new businesses in the first half of the year, at Stockton in Teesside and Castle Bromwich in our Central region, which are both trading well. This investment is focussed on maintaining sustainable market share in these regional markets and will ensure that the growth of the business is well controlled and operating efficiencies continue to be maximised.

Ā 

The Group's drive to capture productivity improvements will support further increases in the number of new homes built, resulting in higher returns on the capital employed in the business being sustained over the long term. Our Space4 insulated panel manufacturing facility will generate increasing efficiency gains with the planned further increases in output. We anticipate that this approach, together with the disciplined deployment of capital within the business, will achieve further improvement in the Group's return on capital employed from 27.5% reported at the half year.

Ā 

The lower land cost recoveries on legal completions taken from our newly opened sites and the additional cost efficiencies captured from increased production will benefit the second half out-turn. Our operating margin continues to move forward and we expect further progress in the second half of the year from 20.5% achieved in the first six months. We are now fully sold up for the current year and have c. £780 million of forward sales reserved beyond 2015, an increase of 12% on the same point last year (2014: £696 million).

Ā 

Land availability is improving as a result of the consistent application of the National Planning Policy Framework with Local Plans identifying sustainable locations for residential development in increasing numbers. We remain focussed on investing in high quality land at this point in the cycle to provide a platform for the Group to deliver superior returns and cash generation over the longer term. To date the Group has acquired over 16,000 plots of new land during the current year. Looking ahead, we anticipate further good success in converting our strategic land into land with residential consent and have delivered c. 25% of the replacement land acquired so far this year from our strategic land portfolio.

Ā 

The cash efficiency of the Group's operations remains a top priority for management, alongside disciplined land replacement. The Group is likely to hold increased cash balances at the year end (31 December 2014: £378.4 million) subject to the timing of further land investment.

Ā 

We will give a further update on progress and trading following the year end on Thursday 7 January 2016.

Ā 

Jeff Fairburn and Mike Killoran will host a conference call with analysts at 9.00 a.m. today. To participate please dial +44(0) 20 3427 1918. The password is "Persimmon".

Ā 

Further information, please contact:

Persimmon plc Citigate Dewe Rogerson

Ā 

Jeff Fairburn, Group Chief Executive Simon Rigby

Mike Killoran, Group Finance Director Kevin Smith

Ā 

Tel: +44 (0)1904 642199 Tel: +44 (0)20 7638 9571

Ā 

This information is provided by RNS
The company news service from the London Stock Exchange
Ā 
END
Ā 
Ā 
TSTLLFFDLILVIIE
Date   Source Headline
1st May 20257:00 amRNSAGM Trading Statement
25th Apr 202510:54 amRNSHolding(s) in Company
25th Apr 20259:24 amRNSHolding(s) in Company
11th Apr 20254:22 pmRNSHolding(s) in Company
3rd Apr 202510:15 amRNSHolding(s) in Company
2nd Apr 202512:22 pmRNSHolding(s) in Company
1st Apr 202512:03 pmRNSTotal Voting Rights
31st Mar 20253:14 pmRNSDirector/PDMR Shareholding
27th Mar 202510:08 amRNSHolding(s) in Company
25th Mar 20253:14 pmRNSDirector/PDMR Shareholding
24th Mar 20253:35 pmRNSAnnual Report 2024 and Notice of AGM 2025
24th Mar 20252:24 pmRNSHolding(s) in Company
11th Mar 20257:00 amRNSFull Year Results
6th Mar 20252:06 pmRNSHolding(s) in Company
3rd Mar 20253:35 pmRNSHolding(s) in Company
3rd Feb 202512:26 pmRNSTotal Voting Rights
14th Jan 20257:00 amRNS2024 Trading Statement
2nd Jan 20251:00 pmRNSTotal Voting Rights
10th Dec 20243:47 pmRNSDirectorate Change
2nd Dec 20242:11 pmRNSBlock listing Interim Review
2nd Dec 202412:00 pmRNSTotal Voting Rights
6th Nov 20247:00 amRNSQ3 Trading Statement
5th Nov 20241:31 pmRNSHolding(s) in Company
1st Nov 20243:59 pmRNSTotal Voting Rights
1st Oct 20241:19 pmRNSTotal Voting Rights
24th Sep 202412:25 pmRNSDirector/PDMR Shareholding
2nd Sep 20241:44 pmRNSTotal Voting Rights
8th Aug 20247:00 amRNSHalf Year Results
1st Aug 20242:32 pmRNSTotal Voting Rights
23rd Jul 202410:28 amRNSDirectorate Change
1st Jul 20241:10 pmRNSTotal Voting Rights
19th Jun 20242:48 pmRNSDirector/PDMR Shareholding
3rd Jun 202412:33 pmRNSBlock listing Interim Review
3rd Jun 202411:08 amRNSTotal Voting Rights
23rd May 20247:00 amRNSConfirmation of CFO start date
1st May 20241:11 pmRNSTotal Voting Rights
30th Apr 20242:03 pmRNSDirectorate Change
25th Apr 20242:09 pmRNSResult of AGM
25th Apr 20247:00 amRNSQ1 Trading Statement
2nd Apr 20241:49 pmRNSTotal Voting Rights
28th Mar 202412:53 pmRNSDirector/PDMR Shareholding
25th Mar 20244:47 pmRNSDirector/PDMR Shareholding
25th Mar 20242:07 pmRNSAnnual Report 2023 and Notice of AGM 2024
12th Mar 20241:38 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSFull Year Results
11th Jan 20246:00 pmRNSDechra Pharmaceuticals
10th Jan 20247:00 amRNSTrading Statement
1st Dec 20234:48 pmRNSBlock listing Interim Review
1st Dec 20234:45 pmRNSTotal Voting Rights
17th Nov 202310:25 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.